EPA Transcriptomic Assessment Products (ETAP) Panel
About the ETAP Panel
The EPA Transcriptomic Assessment Product (ETAP) is a proposed ORD assessment product that utilizes a standardized short-term in vivo study design and data analysis procedures to develop transcriptomic-based reference values for data poor chemicals. To learn more, please visit epa.gov/etap.
Upcoming Meetings & Materials
Past Meetings & Materials
Panel Members
Co-Chairs
Katherine von Stackelberg, Sc. D.
Senior Research Scientist
Harvard T.H. Chan School of Public Health
Justin "Craig" Rowlands, Ph.D.
Principal R&D Toxicologist
UL Solutions, LLC
Members
Thomas Burke, Ph.D., MPH
Professor Emeritus
Johns Hopkins Bloomberg School of Public Health
Harvey Clewell, Ph.D.
Consultant/Technical Assistance Provider
Ramboll US Consulting Inc.
Stephen Edwards, Ph.D.
Bioinformatics Senior Scientist
RTI International
Rebecca Fry, Ph.D.
Carol Remmer Angle Distinguished Professor and Associate Chair in Environmental Sciences and Engineering
University of North Carolina, Chapel Hill
Xiugong Gao, Ph.D.
Research Biologist
U.S. Food and Drug Administration (FDA)
Gladys Liehr, Dr. rer. nat.
Chief of the Bureau of Environmental Health
Florida Department of Health
Gloria Post, Ph. D., DABT
Research Scientist
New Jersey Department of Environmental Protection
Justin Teeguarden, Ph. D.
Laboratory Fellow, EMSL Chief Science Officer
Pacific Northwest National Laboratory (PNNL)
Chris Vulpe, MD, Ph. D.
Professor
University of Florida, Gainesville
Fred Wright, Ph. D.
Professor and Director
North Carolina State University